The improvement of first-phase insulin response is related to long-term glycemic control in newly diagnosed Type 2 diabetic patients by continuous subcutaneous insulin infusion(CSII)

被引：0
|
作者：
Xu, W [1 ]
Li, YB [1 ]
Liao, ZH [1 ]
Yao, B [1 ]
Chen, XH [1 ]
Weng, JP [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Peoples R China
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
808
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [31] Carbohydrate-to-insulin ratio in type 1 diabetic patients treated with continuous subcutaneous insulin infusion therapy (CSII)
    Gonzalez, C.
    Orellana, I.
    Corcoy, R.
    Alcantara, V.
    Chico, A.
    DIABETOLOGIA, 2013, 56 : S444 - S444
  • [32] Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion
    Noh, Yun-Hee
    Lee, Se-Myung
    Kim, Eun-Ju
    Lee, Hyunil
    Lee, Jun-Ho
    Lee, Ju-Han
    Park, So-Young
    Koo, Ja-Hyun
    Wang, Jun-Ho
    Lim, In-Ja
    Choi, Soo-Bong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (05) : 384 - 391
  • [33] Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients
    Liu, Jianbin
    Liu, Juan
    Fang, Donghong
    Liu, Liehua
    Huang, Zhimin
    Wan, Xuesi
    Cao, Xiaopei
    Li, Yanbing
    ENDOCRINE JOURNAL, 2013, 60 (06) : 725 - 732
  • [34] Fasting Plasma Glucose after Intensive Insulin Therapy Predicted Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients
    Liu, Jianbin
    Liu, Juan
    Li, Yanbing
    DIABETES, 2012, 61 : A268 - A268
  • [35] SELF-ADJUST OF BASAL INSULIN ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) PATIENTS: DOES IT SUPPOSE A BETTER GLYCEMIC CONTROL?
    Pazos-Couselo, M.
    Gonzalez-Rodriguez, M.
    Casanueva, F. F.
    Gude, F.
    Rodriguez, J.
    Rodriguez-Segade, S.
    Garcia-Lopez, J. M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A62 - A63
  • [36] Sustained improvement in hemoglobin A1C during long-term treatment with continuous subcutaneous insulin infusion (CSII) in pediatric patients
    Wallach, EJ
    Iazzetti, L
    Bowlby, DA
    Greig, F
    Patel, A
    Hyman, S
    Boscarino, J
    Rapaport, R
    DIABETES, 2005, 54 : A666 - A666
  • [37] The impacts of short-term continuous subcutaneous insulin infusion therapy on insulin sensitivity and insulin secretion in newly diagnosed type 2 diabetes
    Yang, Zhaojun
    Zhang, Bo
    Chen, Yanyan
    DIABETES, 2008, 57 : A86 - A87
  • [38] Continuous subcutaneous insulin infusion (CSII)of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII
    Hirsch, IB
    Bode, BW
    Garg, S
    Lane, WS
    Süssman, A
    Hu, P
    Santiago, OM
    Kolaczynski, J
    DIABETES CARE, 2005, 28 (03) : 533 - 538
  • [39] Improvement of retinopathy in type 1 diabetic patients (T1D) treated with continuous subcutaneous insulin infusion (CSII)
    Aragona, M
    Giannarelli, R
    Coppelli, A
    Palumbo, F
    Pancani, F
    Del Prato, S
    Marchetti, P
    DIABETES, 2003, 52 : A101 - A102
  • [40] Related Factors of Insulin Dose Setting in Type 2 Diabetic Patients Treated with Continuous Subcutaneous Insulin Infusion
    Xu, Wen
    Zhang, Xiuzhen
    Luo, Sihui
    Zhu, Yanhua
    Yan, Jinhua
    Yao, Bin
    Weng, Jianping
    DIABETES, 2015, 64 : A258 - A258
12345